LON:APH - Alliance Pharma Stock Price, Price Target & More

GBX 78.20 -0.20 (-0.26 %)
(As of 04/24/2018 04:00 PM ET)
Previous CloseGBX 78.20
Today's RangeGBX 77.40 - GBX 79
52-Week RangeGBX 45 - GBX 71.43
Volume899,764 shs
Average Volume488,126 shs
Market Capitalization£323.02 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

About Alliance Pharma (LON:APH)

Alliance Pharma logoAlliance Pharma plc operates as a specialty pharmaceutical company in Europe and internationally. It acquires the rights to established products, and owns or licenses the rights to approximately 90 pharmaceutical and consumer healthcare products. The company provides prescription only medicines, over the counter medications, cosmetics, and nutritional supplements, as well as medical devices. It offers products in various therapeutic areas, including acquired healthcare, cardiovascular, central nervous system, child health, consumer health, dermatology, endocrinology, gastroenterology, obstetrics and gynecology, oral health, oncology, stoma care, toxicology, travel health, urology, vitamins and minerals, and others. The company distributes its products through pharmacies, supermarkets, healthcare distributors, and retailers, as well as online retailers. Alliance Pharma plc was founded in 1996 and is headquartered in Chippenham, the United Kingdom.

Receive APH News and Ratings via Email

Sign-up to receive the latest news and ratings for APH and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Drugs - Generic
Sub-IndustryN/A
SectorMedical
SymbolLON:APH
CUSIPN/A
Phone+44-1249-466966

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins26.73%
Return on Equity14.63%
Return on Assets8.39%

Miscellaneous

EmployeesN/A
Outstanding Shares474,310,000

How to Become a New Pot Stock Millionaire

Alliance Pharma (LON:APH) Frequently Asked Questions

What is Alliance Pharma's stock symbol?

Alliance Pharma trades on the London Stock Exchange (LON) under the ticker symbol "APH."

How often does Alliance Pharma pay dividends? What is the dividend yield for Alliance Pharma?

Alliance Pharma announced a dividend on Tuesday, March 27th. Investors of record on Thursday, June 14th will be given a dividend of GBX 0.89 per share on Wednesday, July 11th. This represents a yield of 1.3%. The ex-dividend date is Thursday, June 14th. This is a positive change from Alliance Pharma's previous dividend of $0.44. The official announcement can be accessed at this link. View Alliance Pharma's Dividend History.

What price target have analysts set for APH?

3 equities research analysts have issued 12-month target prices for Alliance Pharma's stock. Their forecasts range from GBX 59 to GBX 88. On average, they anticipate Alliance Pharma's share price to reach GBX 72.33 in the next twelve months. View Analyst Ratings for Alliance Pharma.

Who are some of Alliance Pharma's key competitors?

Who are Alliance Pharma's key executives?

Alliance Pharma's management team includes the folowing people:
  • Mr. John Dawson, Founder, CEO & Exec. Director (Age 69)
  • Mr. Andrew Timothy Franklin, CFO & Exec. Director (Age 52)
  • Mr. Peter Jonathan Butterfield, Deputy CEO & Exec. Director (Age 42)
  • Mr. Stephen Kidner, Chief Scientific & Operations Officer
  • Mr. Daniel Thomas, Chief Corp. Devel. Officer

Has Alliance Pharma been receiving favorable news coverage?

Media coverage about APH stock has been trending somewhat positive this week, Accern reports. The research firm rates the sentiment of press coverage by reviewing more than 20 million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Alliance Pharma earned a daily sentiment score of 0.22 on Accern's scale. They also gave news coverage about the company an impact score of 48.13 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock's share price in the next several days.

How do I buy shares of Alliance Pharma?

Shares of APH and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Alliance Pharma's stock price today?

One share of APH stock can currently be purchased for approximately GBX 78.20.

How big of a company is Alliance Pharma?

Alliance Pharma has a market capitalization of £323.02 million.

How can I contact Alliance Pharma?

Alliance Pharma's mailing address is Avonbridge House, Bath Road, CHIPPENHAM, SN15 2BB, United Kingdom. The company can be reached via phone at +44-1249-466966.


MarketBeat Community Rating for Alliance Pharma (APH)

Community Ranking:  2.0 out of 5 (star star)
Outperform Votes:  123 (Vote Outperform)
Underperform Votes:  183 (Vote Underperform)
Total Votes:  306
MarketBeat's community ratings are surveys of what our community members think about Alliance Pharma and other stocks. Vote "Outperform" if you believe APH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe APH will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Alliance Pharma (LON:APH) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
3 Wall Street analysts have issued ratings and price targets for Alliance Pharma in the last 12 months. Their average twelve-month price target is GBX 72.33The high price target for APH is GBX 88 and the low price target for APH is GBX 59. There are currently 3 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.002.672.673.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: GBX 72.33GBX 69.67GBX 69.67GBX 59

Alliance Pharma (LON:APH) Consensus Price Target History

Price Target History for Alliance Pharma (LON:APH)

Alliance Pharma (LON:APH) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetDetails
4/17/2018Numis SecuritiesBoost Price TargetBuyGBX 80 -> GBX 88View Rating Details
12/12/2017FinnCapBoost Price TargetBuyGBX 58 -> GBX 70View Rating Details
9/13/2017N+1 SingerReiterated Ratingnot ratedView Rating Details
9/13/2017InvestecInitiated CoverageBuyGBX 59View Rating Details
(Data available from 4/24/2016 forward)

Earnings

Dividends

Alliance Pharma (LON:APH) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
3/27/2018GBX 0.891.3%6/14/20186/14/20187/11/2018
9/13/2017GBX 0.440.84%12/21/201712/21/20171/11/2018
3/29/2017€0.811.7%6/15/20176/15/20177/12/2017
9/14/2016€0.400.83%12/22/201612/22/20161/12/2017
4/7/2016€0.731.53%6/16/20166/16/20167/13/2016
9/9/2015€0.370.66%12/18/201512/18/20151/14/2016
3/25/2015€0.671.67%6/18/20156/18/20157/15/2015
9/10/2014€0.330.99%12/4/201412/4/20141/15/2015
3/26/2014€0.611.75%6/11/20146/11/20147/10/2014
9/11/2013€0.300.86%12/4/201312/4/20131/15/2014
(Data available from 1/1/2013 forward)

Insider Trades

Alliance Pharma (LON APH) Insider Trading and Institutional Ownership History

Insider Trading History for Alliance Pharma (LON:APH)

Alliance Pharma (LON APH) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/14/2017Peter ButterfieldInsiderSell61,846GBX 49£30,304.54
9/22/2016John DawsonInsiderSell3,000,000GBX 45£1,350,000
5/3/2016Cook,DavidInsiderBuy54,492GBX 47£25,611.24
12/22/2015Clifford,NigelInsiderBuy66,740GBX 45£30,033
12/17/2015Smith,Andrew LInsiderBuy75,000GBX 41£30,750
6/23/2015Booley,TonyInsiderSell1,155,000GBX 0.37£4,273.50
6/16/2015Nigel CliffordInsiderBuy58,227GBX 39.50£22,999.67
(Data available from 1/1/2013 forward)

Headlines

Alliance Pharma (LON APH) News Headlines

Source:
DateHeadline
Alliance Pharmas (APH) Buy Rating Reaffirmed at Numis SecuritiesAlliance Pharma's (APH) Buy Rating Reaffirmed at Numis Securities
www.americanbankingnews.com - April 17 at 7:34 PM
Alliance Pharma (APH) PT Raised to GBX 88Alliance Pharma (APH) PT Raised to GBX 88
www.americanbankingnews.com - April 17 at 8:05 AM
Alliance Pharma (APH) PT Lowered to GBX 58 at FinnCapAlliance Pharma (APH) PT Lowered to GBX 58 at FinnCap
www.americanbankingnews.com - April 15 at 9:47 AM
Investors Chronicle: Alliance Pharma, Interserve, Moss BrosInvestors Chronicle: Alliance Pharma, Interserve, Moss Bros
www.ft.com - March 29 at 3:49 PM
Numis Securities Reaffirms Add Rating for Alliance Pharma (APH)Numis Securities Reaffirms Add Rating for Alliance Pharma (APH)
www.americanbankingnews.com - March 27 at 11:31 AM
Mark Slater favourite Alliance Pharma plc could make you richMark Slater favourite Alliance Pharma plc could make you rich
www.msn.com - March 27 at 10:45 AM
4D Pharma To Shortly Begin Clinical Studies On MRx0518 Treatment4D Pharma To Shortly Begin Clinical Studies On MRx0518 Treatment
www.morningstar.co.uk - March 21 at 11:32 AM
2 top growth stocks for February2 top growth stocks for February
www.msn.com - February 11 at 5:44 PM
Alliance Pharma (APH) Receives Buy Rating from Numis SecuritiesAlliance Pharma (APH) Receives Buy Rating from Numis Securities
www.americanbankingnews.com - December 30 at 6:38 PM
FinnCap Raises Alliance Pharma (APH) Price Target to GBX 70FinnCap Raises Alliance Pharma (APH) Price Target to GBX 70
www.americanbankingnews.com - December 25 at 9:26 AM
Alliance Pharma Plc : APH-GB: Dividend Analysis : December 22nd, 2017 (record date) : By the numbers : December 22, 2017Alliance Pharma Plc : APH-GB: Dividend Analysis : December 22nd, 2017 (record date) : By the numbers : December 22, 2017
finance.yahoo.com - December 22 at 10:23 PM
Alliance Pharma plc (APH) to Issue GBX 0.44 DividendAlliance Pharma plc (APH) to Issue GBX 0.44 Dividend
www.americanbankingnews.com - December 16 at 11:16 AM
How Alliance Pharma plc (AIM:APH) Delivered A Better ROE Than Its IndustryHow Alliance Pharma plc (AIM:APH) Delivered A Better ROE Than Its Industry
finance.yahoo.com - December 5 at 3:48 PM
2 secret growth stocks that could make you a fortune - Motley Fool UK2 secret growth stocks that could make you a fortune - Motley Fool UK
www.fool.co.uk - November 27 at 3:25 PM
Alliance Pharma plc (APH) Rating Reiterated by FinnCapAlliance Pharma plc (APH) Rating Reiterated by FinnCap
www.americanbankingnews.com - November 23 at 11:20 PM
Was Alliance Pharma plc’s (AIM:APH) EPS Decline A Part Of Broader Industry Downturn?Was Alliance Pharma plc’s (AIM:APH) EPS Decline A Part Of Broader Industry Downturn?
finance.yahoo.com - November 14 at 4:24 PM
Should You Be Tempted To Buy Alliance Pharma plc (AIM:APH) Because Of Its PE Ratio?Should You Be Tempted To Buy Alliance Pharma plc (AIM:APH) Because Of Its PE Ratio?
finance.yahoo.com - October 25 at 4:59 PM
Alliance Pharma Plc :APH-GB: Earnings Analysis: For the six months ended June 30, 2017 : September 29, 2017Alliance Pharma Plc :APH-GB: Earnings Analysis: For the six months ended June 30, 2017 : September 29, 2017
finance.yahoo.com - October 2 at 3:48 PM
Numis Securities Ltd Reaffirms "Buy" Rating for Alliance Pharma plc (APH)Numis Securities Ltd Reaffirms "Buy" Rating for Alliance Pharma plc (APH)
www.americanbankingnews.com - September 17 at 2:08 PM
N+1 Singer Reaffirms not rated Rating for Alliance Pharma plc (APH)N+1 Singer Reaffirms not rated Rating for Alliance Pharma plc (APH)
www.americanbankingnews.com - September 13 at 11:06 AM
Alliance Pharma plc (APH) Research Coverage Started at InvestecAlliance Pharma plc (APH) Research Coverage Started at Investec
www.americanbankingnews.com - September 13 at 8:05 AM
Alliance Pharma Plc – Value Analysis (LONDON:APH) : September 7, 2017Alliance Pharma Plc – Value Analysis (LONDON:APH) : September 7, 2017
finance.yahoo.com - September 7 at 3:57 PM
Alliance Pharma Plc breached its 50 day moving average in a Bullish Manner : APH-GB : September 6, 2017Alliance Pharma Plc breached its 50 day moving average in a Bullish Manner : APH-GB : September 6, 2017
finance.yahoo.com - September 6 at 3:53 PM
Alliance Pharma plc (APH) Set to Announce Earnings on WednesdayAlliance Pharma plc (APH) Set to Announce Earnings on Wednesday
www.americanbankingnews.com - September 6 at 1:46 AM
FinnCap Reaffirms Buy Rating for Alliance Pharma plc (APH)FinnCap Reaffirms Buy Rating for Alliance Pharma plc (APH)
www.americanbankingnews.com - August 28 at 5:02 PM
Update on Diclectin - London South East (registration) (blog)Update on Diclectin - London South East (registration) (blog)
www.lse.co.uk - July 29 at 3:41 PM
2 terrific value stocks I’d buy today2 terrific value stocks I’d buy today
www.fool.co.uk - July 20 at 5:19 PM
Alliance Pharma says Europe move a Brexit shieldAlliance Pharma says Europe move a Brexit shield
www.marketwatch.com - March 29 at 3:46 PM
Application for admission - Regulatory News, RNS - London South ... - London South East (registration) (blog)Application for admission - Regulatory News, RNS - London South ... - London South East (registration) (blog)
www.lse.co.uk - February 14 at 9:13 PM
PDMR shareholding - London South East (registration) (blog)PDMR shareholding - London South East (registration) (blog)
www.lse.co.uk - February 14 at 4:13 PM
Capital Markets Event - London South East (registration) (blog)Capital Markets Event - London South East (registration) (blog)
www.lse.co.uk - December 8 at 3:49 PM
[$$] Investec director pockets £11m[$$] Investec director pockets £11m
www.ft.com - October 7 at 3:31 PM
Alliance Pharma posts 113% jump in 1H profitAlliance Pharma posts 113% jump in 1H profit
www.marketwatch.com - September 15 at 12:26 PM
Half Year 2016 Alliance Pharma PLC Earnings Release - Before Market OpenHalf Year 2016 Alliance Pharma PLC Earnings Release - Before Market Open
biz.yahoo.com - September 14 at 7:53 AM
3 hot dates for your September investment diaries3 hot dates for your September investment diaries
uk.finance.yahoo.com - September 1 at 11:59 AM

SEC Filings

Alliance Pharma (LON:APH) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Social activity is not available for this stock.

Financials

Financials are not available for this stock.

Chart

Alliance Pharma (LON APH) Stock Chart for Tuesday, April, 24, 2018

Loading chart…

This page was last updated on 4/24/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.